Krane Funds Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Krane Funds Advisors's GILD Position: Q3 2025 in Review
Krane Funds Advisors sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 4,682 shares — an estimated $519K sold.
Krane Funds Advisors first reported a position in GILD in Q4 2020 and held it in 18 quarters. The position peaked at $585K in Q2 2021. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- Krane Funds Advisors reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
- Krane Funds Advisors sold 4,682 Gilead Sciences shares in Q3 2025, an estimated $519K.
- Krane Funds Advisors first reported a position in Gilead Sciences in Q4 2020 and held it in 18 quarters.
- Krane Funds Advisors's Gilead Sciences position peaked at $585K in Q2 2021.
- 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on Krane Funds Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.